Advertisement

Latest News

Moving the Needle in Medicine: Blazing a Trail in Cardiology, with Martha Gulati, MD, MS

6 hours ago

Hear Martha Gulati, MD, MS, reveal how mentorship and have shaped her career in women’s heart care.

APEX: Zumilokibart Shows Durable Response at 52 Weeks in Atopic Dermatitis

7 hours ago

This release by Apogee Therapeutics highlights findings from the phase 2 APEX trial on zumilokibart (APG777) in adults with moderate to severe atopic dermatitis.

VIASKIN Peanut Patch Shows Strong Phase 3 VITESSE Results, With David Fleischer, MD

9 hours ago

In this Q&A, Fleischer discusses clinically meaningful gains in peanut allergy desensitization, strong response rates, and the path toward FDA submission for VP250.

ENCORE: ARIKAYCE Meets End Points, Improves Respiration in MAC Lung Disease

10 hours ago

Phase 3b ENCORE shows inhaled ARIKAYCE boosts culture conversion and symptoms in antibiotic‑naïve MAC lung disease, paving way for 2026 label expansion.

Behind the Guidelines: Top Clinical Takeaways From the 2026 Dyslipidemia Guidelines

10 hours ago

New dyslipidemia guidance sharpens risk with CAC, checks lipoprotein(a), and targets LDL goals using expanded therapies for prevention.

Advertisement
Advertisement